Impact of Oncogeriatric Consultation on Quality of Life of Patients Aged 75 and More With Cancer
NCT ID: NCT05163015
Last Updated: 2022-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2022-01-04
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization and Improvement of Care Course for 75 Years and Over Patient With Cancer and Living in Nursing Home on the Marseille Agglomeration
NCT03103659
Deployment of Teleconsulting in Geriatric Oncology for Older Patients
NCT05619731
Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia
NCT03743961
Determinants of Quality Of Life in AGEd Cancer Patients
NCT02672657
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
NCT02821793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with oncogeriatric consultation
with oncogeriatric consultation" group: patients aged 75 and more with cancer with oncogeriatric consultation
Data collection
Description: quality of life assessment
without oncogeriatric consultation
without oncogeriatric consultation" group: patients aged 75 and more with cancer without oncogeriatric consultation
Data collection
Description: quality of life assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Description: quality of life assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged of 75 and more
* with cancer
* with indication of oncogeriatric consultation according G8
* agreeing to participate in the study
Exclusion Criteria
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Godinot
Reims, Grand Est, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-009-ONCOGERIA-QDV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.